Abbott (NYSE: ABT) today the FDA approved its CardioMEMS Hero next-generation pulmonary artery (PA) pressure reader.

Abbott Laboratories will divest its eye care division to Johnson & Johnson for about $4.33 billion in cash, reported Reuters. Here are five things to know about the deal. Abbott, which recently ...

Abbott Park, Ill.-based Abbott Laboratories and Saint Paul, Minn.-based St. Jude Medical — which Abbott is in the process of acquiring for $25 billion — plan to sell several medical devices to ...

Abbott (ABT) ended the recent trading session at $115.29, demonstrating a +2.74% change from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily loss of ...

We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other best medical device ...

The Federal Trade Commission approved Abbott Park, Ill.-based Abbott Laboratories’ proposed acquisition of Little Canada, Minn.-based St. Jude Medical for $25 billion. Here’s what you should know. 1.

Abbott (ABT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Abbott boasts strong profitability, stable margins, and impressive long-term growth, but recent sales have stagnated due to declining COVID-related diagnostics revenue. Medical devices, especially ...

(NBC CHICAGO) — The Food and Drug Administration issued an alert about a "potentially high-risk issue" regarding malfunctioning Abbott glucose sensors that have been linked to more than 700 serious ...